CAR-T Treatment for Relapse / Refractory Type Safety and Effectiveness of Lymphoma

Name: CAR-T Treatment for Relapse / Refractory Type Safety and Effectiveness of Lymphoma
License: Public Domain

Sinobioway Cell Therapy Co., Ltd.

ClinicalTrials.gov · Datasets · License: Public Domain

lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 424176
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.